1don MSN
Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities
Multiple myeloma is a cancer that develops in bone marrow plasma cells, crowding out healthy blood cells and damaging the bones.
Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and ...
Confirming what many cancer specialists have long believed, British researchers have shown that high-dose chemotherapy and a stem cell transplant together are far more effective against the bone ...
Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved ...
Bone cancer in the leg, while relatively uncommon, presents with specific warning signs that warrant immediate medical attention. Understanding these symptoms enables individuals to seek prompt ...
Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...
Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital has secured a £110,000 grant from Orthopaedic Research UK to ...
The drug pazopanib (Votrient) extended the lives of a small group of kids with Ewing sarcoma, which causes cancerous tumors ...
MedPage Today on MSN
De-Escalating Bone-Modifying Therapy Safe, Effective in Metastatic Breast Cancer
BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results